Physician profile
Eric Christopher Riedinger
NPI 1255860672
$27,139.77
in general payments reported to CMS, 2019-2025
23 companies · $1,064 in 2025
The $1,064 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $202 · 2023: $25K · 2024: $690 · 2025: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $1,938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Food and Beverage | $1,938.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,638.73 | 2022-2025 | Lithoclast, Lithovue, General - Female Sui |
| Urogen Pharma, INC. | $371.94 | 2024-2025 | |
| Teleflex LLC | $213.67 | 2025 | Barrigel, Urolift |
| Endo USA, INC. | $160.46 | 2024-2025 | Xiaflex, Aveed |
| Janssen Scientific Affairs, LLC | $124.99 | 2024 | Erleada |
| Ethicon US, LLC | $115.48 | 2025 | Ethicon, Vistaseal, Surgiflo Hemostatic Matrix |
| Medtronic, INC. | $71.41 | 2024 | Interstim |
| Calyxo, INC. | $63.91 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $52.19 | 2022-2025 | |
| Abc Home Medical Supply, INC. | $38.68 | 2022-2025 | |
| Astellas Pharma US INC | $37.02 | 2022 | |
| Axonics, INC. | $34.35 | 2024 | Axonics |
| Janssen Biotech, INC. | $32.86 | 2023-2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $24.93 | 2025 | |
| Abbvie INC. | $24.45 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $21.08 | 2022 | |
| Immunitybio, INC. | $21.06 | 2025 | |
| Cook Medical LLC | $17.16 | 2024 | Litho 150 |
| Coloplast Corp | $17.00 | 2025 | |
| Photocure INC | $15.84 | 2025 | Cysview |
| Ferring Pharmaceuticals INC. | $14.59 | 2024 | Adstiladrin |
| Laborie Medical Technologies Corp. | $14.48 | 2025 | |
| Sumitomo Pharma America, INC. | $13.49 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Riedinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.